BioPharmSignal logoBioPharmSignal

Biotech News

Achieve Life Sciences Appoints Jeffrey Farrow and Reid Waldman, MD to Board of Directors

Achieve Life Sciences (ACHV)Achieve Life SciencesCompany update

ACHV (ACHV) appears in the live feed after a catalyst-style update. The headline is surfaced in real time so readers can move from signal to source without leaving the product flow.

The source domain is achv.com. BioPharmSignal keeps the ticker, timestamp, and source together for faster review before the wider market catches up.

The original release is available below in a new tab so readers can continue into the full source when needed.

Related news

ACHVAchieve Life Sciences2026-08-03 12:30 EST

Achieve Life Sciences Appoints Ronald Dadino and Gloria Cosgrove to Lead CMC, Supply Chain, and Quality

ACHVAchieve Life Sciences2026-03-26 12:30 EST

Achieve Life Sciences Announces Publication in Nicotine & Tobacco Research Linking Cytisinicline's Receptor Selectivity to Low Nausea Rates and Favorable Tolerability

KZRKezar Life Sciences2019-12-19 12:00 EST

Kezar Life Sciences Enhances Clinical Expertise with the Appointment of Elizabeth Garner, MD, MPH to its Board of Directors

WVEWave Life Sciences2026-07-30 11:30 EST

Wave Life Sciences Reports Second Quarter 2026 Financial Results and Provides Business Update

WVEWave Life Sciences2026-06-24 12:30 EST

Wave Life Sciences Announces Initiation of Phase 2a Portion of INLIGHT™ Trial of WVE-007 (INHBE GalNAc-siRNA) for Obesity and Cardiometabolic Diseases

SLSSELLAS Life Sciences Group, Inc.2026-05-12 20:05 EST

SELLAS Life Sciences Reports First Quarter 2026 Financial Results and Provides Corporate Update

AZTAAzenta Life Sciences2026-04-07 12:15 EST

Azenta Life Sciences Announces Leadership Transition to Accelerate Gene Synthesis Strategy and Multiomics Execution

SLSSELLAS Life Sciences Group, Inc.2026-03-19 20:05 EST

SELLAS Life Sciences Reports Full Year 2025 Financial Results and Provides Corporate Update

KZRKezar Life Sciences2020-05-07 20:01 EST

Kezar Life Sciences Reports First Quarter 2020 Financial Results and Provides Business Update

View all latest news

Achieve Life Sciences

Nicotine Dependence Company Achieve Life Sciences develops cytisinicline as a treatment for nicotine dependence and smoking cessation. Cytisinicline Cytisinicline is a plant-derived partial agonist of the nicotinic acetylcholine receptor and is intended as a shorter-course alternative to existing prescription therapies. Phase 3...

Recent company news

ACHVAchieve Life Sciences2026-08-03 12:30 EST

Achieve Life Sciences Appoints Ronald Dadino and Gloria Cosgrove to Lead CMC, Supply Chain, and Quality

ACHVAchieve Life Sciences2026-07-31 12:30 EST

Achieve Life Sciences Announced Granting of New Hire Inducement Awards

ACHVAchieve Life Sciences2026-06-29 12:30 EST

Achieve Life Sciences Joins Russell 2000® Index

ACHVAchieve Life Sciences2026-06-22 12:30 EST

Achieve Life Sciences Receives Complete Response Letter from FDA for Cytisinicline NDA

ACHVAchieve Life Sciences2026-06-02 12:30 EST

Achieve Life Sciences Appoints Jeffrey Farrow and Reid Waldman, MD to Board of Directors

Stock data

Close
6.55 USD
Market cap
516.38M USD
Exchange
NASDAQ
Sector
Life Science Tools
Location
United States